Early ovarian cancer (Stage I) Conclusions from GOG #157 – No difference in recurrence or survival with 6 cycles of C/T vs.
{"Image DocumentName": "Early ovarian cancer (Stage I)", "Image ImageDescription": "Results- Median duration of follow-up 6.8 years. Estimated cumulative incidence of cancer recurring within 5 years. 25.4% (3 cycles) vs. 20.1% (6 cycles) Adjusting stage and grade, 24% less recurrence rate for patients treated with 6 cycles [HR 0.761, (95% CI=0.512\u20131.13) p=0.18] Estimated probability of surviving 5 years. 81% (3 cycles) vs. 83% (6 cycles) [HR 1.02; (95% CI=0.662\u20131.57) p=0.94]. No difference in recurrence rate between incompletely staged and completely staged patients.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}